Concepedia

Nicole L Byers

NL

7

Publications

791

Citations

7

H-Index

2013

Active since

Affiliations

Eli Lilly (United States)(Current)

Karolinska Institutet

Luigi Sacco Hospital

University of Oxford

University of Milan

Nicole L Byers is an author at Eli Lilly (United States) specializing in immunotherapy, molecular diagnostics, and innate immunity.

Top concepts

Publications per year

2013–2020

7

Publications

7

Comparison of baricitinib, upadacitinib, and tofacitinib mediated regulation of cytokine signaling in human leukocyte subpopulations

Iain B. McInnes, Nicole L Byers, Richard E. Higgs et al. · Arthritis Research & Therapy · 2019 · 272 citations · Full text

Mechanism of baricitinib supports artificial intelligence‐predicted testing in <scp>COVID</scp> ‐19 patients

Justin Stebbing, Venkatesh Krishnan, Stephanie de Bono et al. · EMBO Molecular Medicine · 2020 · 262 citations · Full text

Infections in baricitinib clinical trials for patients with active rheumatoid arthritis

Kevin Winthrop, Masayoshi Harigai, Mark C. Genovese et al. · Annals of the Rheumatic Diseases · 2020 · 89 citations · Full text

Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathways

Thomas Dörner, Yoshiya Tanaka, Michelle Petri et al. · Lupus Science & Medicine · 2020 · 60 citations · Full text

Multicentre randomized controlled trial of structured transition on diabetes care management compared to standard diabetes care in adolescents and young adults with type 1 diabetes (Transition Trial)

Tamara Spaic, Jeff Mahon, Irene Hramiak et al. · BMC Pediatrics · 2013 · 41 citations · Full text

Rows per page

1–5 of 7